Onyema Ogbuagu

Onyema Eberechukwu Ogbuagu (born June 20, 1978) is an American-born infectious diseases physician, educator, researcher, and clinical trial investigator, who was raised and educated in Nigeria. He is an associate professor at Yale School of Medicine in New Haven, CT and is the director of the Yale AIDS Program clinical trials unit. His research contributions have focused on HIV/AIDS prevention and COVID-19 vaccination and treatment clinical trials. He switched his focus at the beginning of the 2019 COVID pandemic and participated as a principal investigator (PI) on the Pfizer-BioNtech COVID-19 vaccine trials and the Remdesivir SIMPLE trial in 2020 and 2021. In pursuit of his global health component of his career, Ogbuagu also supports postgraduate physician medical education programs in low and middle income countries in sub-Saharan Africa in Rwanda (2013–2018) and Liberia (2017 to date) as well as HIV treatment programs in Liberia (2018 to date).

In his role as public health educator, he has worked to increase public understanding of mRNA vaccines. Ogbuagu has also worked to decrease vaccine hesitancy. He has been a co-author on 43 scholarly articles, according to the National Library of Medicine. According to Google Scholar, one article he co-authored on Remdesivir and its use for Covid that appeared in JAMA was cited 504 times. Ogbuagu was selected as the commencement speaker for Yale School of Medicine's class of 2021. Provided by Wikipedia